Lipopolysaccharides (LPS) of Gram negative bacteria are one of the most potent stimulators of the host innate immune system and LPS recognition is essential for the host organism to clear infections of invading bacterial pathogens. Here we review on the latest research on how LPS is sensed by host cells and how distinct LPS structures differentially modulate the strength of the host immune response. Much is known about host immunological reactions towards pathogens via recognition of their LPS, as well as strategies of pathogens to modulate their LPS structure in order to evade the immune system. However, less is known about differential sensing of lipopolysaccharides of commensal bacteria in the intestine and how this contributes to manifestation or destruction of the intestinal homeostasis. LPS sensing is necessary to fight pathogens. However, sensing of LPS of gut commensal bacteria can simultaneously be disadvantageous for the genetically predisposed host, since this might lead to damage of the intestinal homeostasis and therefore to chronic intestinal inflammation. However, less immunogenic LPS could also serve as therapeutics to antagonize an overreacting innate immune system. Therefore, commensal gut bacteria-derived LPS could prevent from uncontrolled intestinal immune response in the intestine which makes LPS an attractive therapeutical approach to treat e.g. IBD.
Introduction
Lipopolysaccharides fulfil two major functions. First, the LPS anchored in the outer bacterial membrane provides a protective function for Gram negative bacteria and therefore acts as a defence mechanism against harsh environmental conditions. It provides a barrier against surrounding stress factors which therefore makes LPS indispensable for bacterial viability in various distinct ecosystems (Silipo et al., 2012) . By substituting the lipid A sugar moieties with phosphate groups, the bacterium achieves to create a negatively charged outer membrane which can therefore interact with divalent cations present in the surrounding milieu. This plays an important role for the rigidity and the tightness of the outer membrane and hence mediates bacterial resistance to external stress factors (Alexander and Rietschel, 2001) . Second, LPS is one of the most conserved structures within all Gram negative bacterial species. This makes LPS an important pathogen associated molecular pattern (PAMP) to be recognized by the mammalian innate immune system which can subsequently initiate the clearance of a bacterial infection. This important immunological reaction general is highly conserved, which is important for host receptor recognition.
Lipid A
Basically, lipid A is made up of a ˇ(1 → 6)-linked glucosamine disaccharide backbone which is mostly phosphorylated at position 1 and 4 of the saccharides and acylated at positions 2 and 3 of each monosaccharide portion (Galanos and Freudenberg, 1993; Homma et al., 1985; Kotani et al., 1985) .
Usually, lipid A is hexaacetylated, meaning that six acyl chains of variable length are esterified with the disaccharide backbone. Primary acyl chains are directly esterified with the sugar moiety while so-called secondary acyl chains form ester bonds with hydroxyl groups of primary acyl chains. "Symmetrically" acetylated lipid A means that each glucosamine moiety carries the same number of acyl chains. Escherichia coli LPS is an example for containing an "asymmetrically" acetylated lipid A, since 4 of its 6 acyl chains are carried by the first glucosamine. Lipid A is embedded in the outer leaflet of the bacterial outer membrane through electrostatic and mainly hydrophobic interactions. Here, the diglucosamine part of the lipid A is orientated towards the exterior environment while the lipid A acyl chains point to the hydrophilic interior of the membrane (Raetz and Whitfield, 2002) . Fig. 2 illustrates the detailed structure of E. coli lipid A which is considered to be the prototype form of all lipid A structures. Its two glucosamine residues are each substituted by a phosphate residue at positions 1 and 4 , respectively. The hydroxyl groups at positions 2 and 3 of each monosaccharide are esterified with hydroxymyristate, a saturated acyl chain with 14 carbon atoms, as primary acyl chain. Two additional secondary acyl chains, laurate (C 12 ) and myristate (C 14 ) , are coupled to hydroxymyristates at positions 2 and 3 (Raetz and Whitfield, 2002) (Fig. 2) .
However, Lipid A structures widely vary among the different bacterial species. Sometimes there are even more than one different lipid A structure within a single species (Raetz and Whitfield, 2002) . The sugar moieties of the saccharide backbone are mostly 2-amino-2-deoxy-d-glucopyranoses (d-GlcpN) like in E. coli lipid A, but can also be, i.e. 2,3-diamino-2,3-dideoxy-dglucopyranose (d-GlcpN3N) containing an additional amino group (Molinaro et al., 2015; Roppel and Mayer, 1975) . Other potential differences refer to the number, position and length of the esterified acyl chains, the presence of charged groups on the polar heads as well as the number of phosphate groups coupled to the disaccharide backbone (Raetz et al., 2007) . The lipid A part of LPS is coupled to the core region through linkage via the nonreducing distal amino sugar of lipid A (Molinaro et al., 2015) (Fig. 2) .
In E. coli lipid A, C12 and C14 acyl chains are the only ones being esterified with the disaccharide backbone (Fig. 2) . However, other bacteria can provide differentially acylated lipid A which is supposed to be mediated by other enzymes than the ones in E. coli which are specific for substituting C14 and C12. However, it could be demonstrated that in Bacteroides fragilis and Bordetella pertussis, the enzymes catalysing the acylation of the sugar moieties seem to be multifunctional, therefore being able to recognize more than one specific acyl chain as a substrate (Bainbridge et al., 2008; Sweet et al., 2002) .
The number of acyl chains esterified with the disaccharide backbone varies among the lipid A of different bacterial species. As mentioned above, the prototype hexaacylated lipid A contains six acyl chains. However, certain bacterial species can provide "underacylated" lipid A structures, like tetraacylated Helicobacter pylori lipid A (Mattsby-Baltzer et al., 1992; Moran et al., 1997) (Fig. 4) , or even "overacylated" structures like heptaacylated Acinetobacter spp. lipid A (Leone et al., 2006 (Leone et al., , 2007 .
The phosphorylation pattern of the disaccharide backbone is also not conserved among different bacterial species. As phosphate groups are negatively charged, a more or less phosphorylated lipid A allows bacteria to change the net charge of their surface. This surface net charge may vary considerably dependent on environmental factors like temperature, pH value or, important for immune evasion, the presence of antibiotics and antimicrobial peptides (AMPs). The phosphate groups can mediate interactions with neighbouring phosphorylated lipid A structures via divalent cations being present in the surrounding environment. These interactions considerably increase the stability of the bacterial outer membrane and reduce the permeability of the cell wall (Molinaro et al., 2015) .
Core and O-antigen
The core moiety of LPS starts with at least one residue of 3-deoxy-d-manno-oct-ulosonic acid (Kdo) which is directly linked to one of the sugar moieties of lipid A (Figs. 1 and 2 ). The core contains up to 15 sugar residues and provides antigenic properties in the case of a missing O-antigen (rough-type LPS) (Caroff and Karibian, 2003) . The O-antigen, sometimes also named O-specific polysaccharide or simply "glycan" consists of repeating units of usually not more than five sugar units. The O-antigen can only be found in smooth type LPS where it determines its antigenic properties (Raetz and Whitfield, 2002) .
Molecular weight and micelle formation of isolated LPS
Usually, LPS is anchored in the bacterial outer membrane. However, for immunological sensing by the host immune system it has to be released from the bacterial membrane. The exact conformation of isolated, non-bacterially attached, LPS is not easy to determine. However, this is an important issue for in vitro experiments using isolated LPS in aqueous solutions. Due to its amphiphilic structure, with the acyl chains of the lipid A forming the hydrophobic part and the sugar residues of lipid A, the core and the O-antigen building up the hydrophilic part, isolated LPS rarely forms monomers in any solvent. Therefore, molecular weight determination of either smooth or rough LPS is not trivial. Dependent on the presence of divalent cations, detergents or the pH value of the solvent, these large amphiphilic molecules form either monomers, micelles or even vesicles. The critical LPS concentration in aqueous solutions for micelle formation is stated to be 11 g/mL (Aurell and Wistrom, 1998) . Additionally, micelle formation capacity is dependent on the structure of LPS, especially if it consists of the S-or R-form. These micelles usually provide low solubility in any solvent (Molinaro et al., 2015) . However, the typical molecular weight of monomeric S-form LPS of E. coli is reported to be between 11.8 and 18 kDa.
Biosynthesis of lipopolysaccharides of Gram negative bacteria
The biosynthesis of hexaacetylated E. coli LPS has been described in detail in 2002 by Raetz and Whitfield (Raetz and Whitfield, 2002) . Briefly, the formation of Kdo2-substituted lipid A includes nine enzymatic steps catalyzed by the enzymes LpxA, LpxB, LpxC, LpxD, LpxH, LpxK, LpxL, LpxM and WaaA. This Kdo2 substituted lipid A is synthesized in the bacterial cytosol and acyl chain substitution involves the aid of bacterial acyl carrier proteins. Lipid A-Kdo2 is completely synthesized in the cytosol either by soluble cytosolic proteins or enzymes that are associated with the cytosolic part of the inner bacterial membrane (Carty et al., 1999; Clementz et al., 1996 Clementz et al., , 1997 Garrett et al., 1997; Vorachek-Warren et al., 2002) . The LPS core region is also synthesized in the cytosol. Lipid A-Kdo2 and the core region together form the rough-type (R-) LPS which is transported across the inner membrane into the periplasmatic space. Once located there, R-type LPS can either be directly inserted into the outer leaflet of the outer bacterial membrane or it can be converted into the S-(smooth) type LPS in the periplasmatic space before being shuttled to the outer membrane. The flipping of the lipid A coupled LPS core is carried out by MsbA, an ATP-binding cassette (ABC) transporter protein (Karow and Georgopoulos, 1993; Zhou et al., 1998) .
Although this describes only the events during biosynthesis of LPS in E. coli, the general mechanisms seem to be conserved among most Gram negative bacteria. Bioinformatics-based studies revealed that many Gram negative bacteria share enzymes like the ones that are used in E. coli for LPS biosynthesis. But since lipid A structures differ between distinct bacteria, alterations in the structure are supposed to be due to genetic and/or environmental differences or influences (Molinaro et al., 2015; Raetz et al., 2007) .
Extracellular sensing of LPS through recognition by the MD-2/TLR4 receptor complex
Long time, Toll-like receptor 4 (TLR4) was supposed to be the sole LPS sensor in mammalian organisms. TLR4 is a transmembrane protein composed of 22 leucine-rich repeats (LRRs), one transmembrane domain and a cytosolic Toll/IL-1 receptor (TIR) domain, the latter being a common feature in all TLRs. LPS is anchored in the bacterial outer membrane. However, for being recognized by the host immune system, LPS has to be removed from the membrane or membranous structures. This can either happen indirectly by bacterial cell death leading to a release of LPS or directly by the soluble host protein lipid A-binding protein (LBP), a lipid transferase that is able to remove LPS molecules from the bacterial membrane (Miyake, 2006) . LBP is present in the serum to sense bacterial presence in the blood. Additionally, LBP is secreted into the intestinal lumen where it is involved in sensing not only invading pathogens, but also commensal-derived LPS (Hansen et al., 2009) (Vreugdenhil et al., 2000) . In general, commensal intestinal bacteria can be subdivided into two distinct groups, dependent on their potential to induce disease under certain circumstances: (1) symbiotic bacteria that never induce disease and (2) pathobiontic bacteria which are potentially able to induce pathological immune reactions. Sensing of LPS molecules from these two different bacterial subgroups is important for a balanced intestinal immune system. This fact makes LBP essential for the maintenance of the intestinal homeostasis. LBP transports monomeric lipid A molecules to CD14. CD14 can either be a membrane-anchored protein of TLR4-expressing cells or can be secreted into the environment as a soluble protein. The presence of CD14 is important for LPS sensing, since it increases the susceptibility of TLR4-expressing cells to LPS by factor 10 2 to 10 3 (Wright et al., 1990) . CD14-associated monomeric LPS is then shuttled to MD-2 (Fig. 3A) . Like CD14, MD-2 can be a soluble protein secreted into the cell exterior or it can be permanently attached to a TLR4 monomer via hydrogen bonds Visintin et al., 2003) . Binding of LPS to MD-2 leads to formation of a heterooligomeric protein complex consisting of two MD-2 and two TLR4 molecules (Fig. 3A) . This protein complex formation is initially induced through interaction at the extracellular domains. These extracellular protein-protein-interactions, in turn, result in dimerization of TIR-domain containing intracellular cytosolic parts of the TLR4 receptors leading to Myeloid differentiation primary response gene 88 (MyD88)-or TIR-domain-containing adapterinducing interferon-␤ (TRIF)-dependent downstream signalling (Molinaro et al., 2015) (Fig. 3A) . Binding of LPS to MD-2 leads to conformational changes within MD-2 therefore promoting MD-2 binding to the ectodomain of TLR4 (Ohto et al., 2007 (Ohto et al., , 2012 . In 2009, Park et al. (2009) revealed interesting detailed informations on the binding conditions within a crystallized hexaacylated LPS-MD-2-TLR4 complex with both, murine and human TLR4 ectodomains. In general, five of the six acyl chains of hexaacylated LPS are buried inside a binding grove in the interior of MD-2. The sixth acyl chain is located on the surface of MD-2 and partially exposed to the surrounding solvent. In combination with hydrophobic residues of MD-2, this 6th acyl chain promotes intermolecular interactions with TLR4 (Jin and Lee, 2008; Ohto et al., 2012) . Taken together, the initial binding of LPS to MD-2 creates a new binding interface for MD-2 and therefore promotes MD-2 binding to TLR4 (Park et al., 2009) . The resulting conformational changes within this complex lead to dimerization of the C-termini of the TLR4 ectodomaines. This event is supposed to mediate the dimerization also of the cytosolic TIR domains of the TLR4 which initializes intracellular downstream signalling (Jin and Lee, 2008; Kim et al., 2007; Ohto et al., 2012) (Fig. 3A) . Taken together, MD-2 binding of lipid A is essential for TLR4-mediated LPS recognition. However, LBP and CD14 are supposed to be important for LPS sensing at low LPS concentration whereas they seem to be dispensable at high concentrations (Wurfel et al., 1995; Wurfel and Wright, 1997) . Activation of the TLR4-receptor complex results in an activation of more than 10 3 genes (Bjorkbacka et al., 2004) and promotes, i.e. the secretion of pro-inflammatory cytokines like TNF, IL-6, IL-1␤ as well as in enhanced production of the superoxide anion O 2 − , hydroxyl radicals, NO and antimicrobial peptides (AMPs) (Ohto et al., 2007; Poltorak et al., 2000) (Fig. 3A) .
Intracellular sensing of LPS through recognition by cytosolic caspase-11
Caspases are intracellular cysteine proteases. The so-called "inflammatory caspases" comprise a certain subset of these enzymes which are critical for clearance of microbial infections and initiation of the host immune system to fight pathogens (Lamkanfi et al., 2002; Martinon and Tschopp, 2004) . Among others, murine caspases 1, 4, 5 and 11 as well as human caspases 4 and 5 are considered to be such inflammatory caspases. They all have in common that they are synthesized as proteolytically inactive zymogens, needing proteolytic cleavage to induce enzymatic activity. Furthermore, they share an N-terminal domain responsible for protein-protein interactions called caspase activation and recruitment domain (CARD). All genes of inflammatory caspases are encoded in an inflammatory gene cluster. Once activated, inflammatory caspases lead to the maturation of the pro-inflammatory cytokines IL-1␤ and IL-18 and induce a special kind of cell death, pyroptosis. Both mechanisms are mediated by activation of cytosolic inflammasomes. Inflammasome activation can be carried out through two different mechanisms: the canonical and non-canonical way. The classical, or "canonical" way to activate inflammasomes in a caspase-dependent manner, involves proteins like Nod-like receptor protein 3 (NLRP3) or NLR family CARD domain-containing protein 4 (NLRC4) engaging the intracellular adaptor protein NLR family CARD domain-containing protein 4 (ASC) resulting in an activation of caspase-1 (Casp1) which leads to a Casp1-catalyzed cleavage of IL-1␤ and IL-18 followed by secretion of the mature cytokines (Mariathasan et al., 2006; Martinon et al., 2006; Schroder and Tschopp, 2010) . The non-canonical way includes Casp1 activation with the requirement of Casp11 (Wang et al., 1996) . Interestingly, Casp11 can directly sense the presence of cytosolic lipid A independently from TLR4 recognition but also leading to inflammasome activation and consequently to IL-1␤ and IL-18 secretion as well as pyroptosis (Fig. 3B) .
The non-canonical inflammasome activation requires two independent activation steps: First, a priming signal that leads to an increase in intracellular expression of inflammasome components like Casp1, NLRP3, ASC and Casp11. This initial event can be lipid A binding to TLR4 (Raetz and Whitfield, 2002) which efficiently enhances Casp11 gene transcription Kayagaki et al., 2013; Wang et al., 1996) . However, the priming event is not restricted to TLR4 recognition of lipid A. In fact, activation of TLR2 and/or TLR7 by other bacterial components is sufficient to act as such a priming signal (Takeuchi and Akira, 2010) . Second, after the priming event, intracellularly located LPS can directly bind to Casp11 leading to its activation which subsequently results in inflammasome activation. It could already be shown that this Casp11-mediated non-canonical inflammasome activation, independent of TLR4 activation, plays an important role during bacterial challenge of the host with pathogens like Shigella flexneri (Rathinam et al., 2012) , Salmonella typhimurium (Broz et al., 2012a) , Legionella pneumophila (Case et al., 2013) or Burkholderia thailandiensis but is also important for sensing the LPS of gut commensals like E. coli (Kayagaki et al., 2013) . Furthermore, it seems that Casp11-mediated sensing of Gram negative bacteria is not just an alternative to the TLR4-mediated way but rather seems to be critical for an adequate response of the immune system to these bacteria Broz et al., 2012b; Kayagaki et al., 2011; Rathinam et al., 2012) .
But how can lipid A of non-invading bacteria like E. coli be sensed intracellularly by cytosolic inflammasome components? As known so far, Casp11 non-canonical inflammasome activation mostly occurs in macrophages in mice, although a recent publications reports on Casp11 expression in mouse epithelial cells (Knodler et al., 2014) . Macrophages are phagocytes which can include The host lipid binding protein (LBP) samples LPS from the outer membrane of Gram negative bacteria and mediates its transport to host CD14. CD14 can either be soluble (sCD14) or anchored in the membrane of TLR4 expressing cells. CD14 shuttles LPS to the TLR4 coreceptor protein MD-2 which initiates a conformational change in MD-2 and TLR4, resulting in dimerization of the extracellular and subsequently of the intracellular TIR domains. TIR domain dimerization mediates downstream signaling leading to enhanced expression of more than 1000 different genes. (B) Intracellular LPS sensing. Left side: LPS that is present in the extracellular space can enter (for example by, but not exclusively due to, receptor-mediated endocytosis) the vacuoles of caspase-11 (Casp11) expressing cells. LPS escapes the vacuoles via a yet unidentified mechanism. Right side: Gram negative bacteria can be sampled by phagocytotic cells like Casp11 expressing macrophages. The LPS of non-cell invading bacteria or whole cell invading bacteria are relieved into the cytosol. Both: LPS present in the cytosol actively binds to the CARD domain of Casp11 leading to Casp11 oligomerization that results in Casp11 activation. By a yet unknown mechanism, this Casp11 activation results in inflammasome assembly resulting in Caspase-1 (Casp1) mediated secretion of the pro-inflammatory cytokines IL-1␤ and IL-18. Casp11 oligomerization can also lead to pyroptosis, a special kind of cell death. extracellular bacteria into vacuolar phagolysosomes. Some bacteria, which are specialized in intracellular replication, like Burkholderia spp. can actively escape the phagosomes into the cytosol of host macrophages where they can trigger LPS-dependent Casp11 activation . Salmonella typhimurium is able to rupture the membrane of the bacteria-containing vacuole with the use of Guanine-binding protein 2 (GBP2). However, the presence of GBP2 is obviously dispensable for Casp11-mediated sensing of S. typhimurium LPS (Kayagaki et al., 2013) , although other studies report GBPs to be critical for the release of vacuole content (Meunier et al., 2014; Pilla et al., 2014) . How LPS of other Gram negative bacteria which are not specialized in host cell invasion like E. coli or Citrobacter rodentium (Kayagaki et al., 2013; Meunier et al., 2014) can be translocated from the vacuole to the cytosol of host macrophages in order to be sensed by Casp11 is unknown so far (Fig. 3B) . Most in vitro studies therefore used methods like electroporation or transfection to make cytosolic Casp11 capable of LPS sensing.
It is already clear that, lipid A is the decisive part for intracellular Casp11-mediated LPS sensing Kayagaki et al., 2013) , just like it is the case for TLR4-mediated recognition of LPS. It could also be shown that the categories "antagonistic" and "agonistic" in terms of LPS endotoxicity can also be referred to lipid A-induced Casp11 activation, since lipid A structures that are weakly agonistic or antagonistic for TLR4 activation also fail to induce Casp11 activation Kayagaki et al., 2013) . This is not due to a lower affinity for lipid A to Casp11 since it could be demonstrated that these less agonistic lipid A structures efficiently bind to Casp11 (Shi et al., 2014) . However, it is not known if the same structural criteria for being agonistic or antagonistic, which are valid in case of MD-2/TLR4-mediated lipid A sensing, also counts for Casp11. When lipid A is located in the cytosol, it is able to directly bind to Casp11 with the help of the Casp11-intrinsic CARD domain subsequently leading to Casp11 oligomerization (Shi et al., 2014) . The exact mechanisms behind these findings are not understood so far. However, it is clear that this lipid A-induced Casp11 oligomerization leads to proteolytical activation of Casp11 within the oligomer (Shi et al., 2014; Shin et al., 2007) . Lipid A binding to Casp11 is highly specific, since no other LPS component could be shown to interact with Casp11 and, inversely, no other caspase interacts with lipid A (Shi et al., 2014) . Caspase-11 (Casp11) was initially discovered by Wang et al (Wang et al., 1996) and two corresponding orthologues of murine Casp11 could be discovered in humans: caspase-4 (Casp4) and caspase-5 (Casp5) (Stowe et al., 2015) .
Other host proteins being involved in LPS sensing
Apolipoprotein CI (ApoCI) is a small apolipoprotein which is present in the serum. It has been shown to provide an LPS-binding motif with which it is able to bind to bacterial LPS, finally enhancing an LPS induced inflammatory host response (Berbee et al., 2006) . It seems to act in a comparable way like LBP and promotes CD14/MD-2/TLR4-mediated LPS signalling (Berbee et al., 2010) . By its strong affinity to bacterial LPS it enhances the residence time of LPS in the circulation (Berbee et al., 2006) . This makes ApoCI an important feature to protect from fatal sepsis, since the prolonged residence time enhanced the access for LPS-sensing blood cells in order to fight invading pathogens, as demonstrated in a Klebsiella pneumoniae sepsis model (Berbee et al., 2006) . Acyloxyacyl hydrolase (AOAH) is an enzyme, expressed in host antigen presenting cells, that renders agonistic lipid A into non-TLR4 signaling structures by removing acyl chains from the lipid A disaccharide backbone (Munford and Hall, 1986) . AOAH is a critical enzyme when it comes to inactivation of agonistic LPS of pathogens and endotoxin tolerance. Such a tolerance towards pathogen-derived lipid A diminishes the immune response of the host to fight these invading microbes (Lu et al., 2008) . The restoration of a powerful immune response is dependent on the inactivation of the pathogen's lipid A, making AOAH crucial in this context (Lu et al., 2008) . The impact of AOAH on inactivation of commensal lipid A is less clear. It could be shown that AOAH is preferentially expressed in a Th17-immune response mediating dendritic cell subpopulation and that AOAH deficiency favours induction of T reg cells over induction of Th17 cells (Janelsins et al., 2014) . However, the correlation between AOAH activity, microbiota composition (and therefore lipid A structures) and the outcome of inflammatory bowel disease still needs to be elucidated.
Immunogenicity of lipopolysaccharide
As already mentioned, LPS structure, especially its lipid A chemistry, differs among distinct bacterial species. Indeed, the exact LPS structure, and in this context mainly the lipid A structure, determines LPS immunogenicity and is therefore decisive for its function (Brandenburg et al., 1993; Seydel et al., 2000) . LPS which triggers a strong pro-inflammatory reactions of host cells are named "agonistic" lipolysaccharides. In contrast, structurally different lipid A can also result in weak inflammatory host responses, hence being called "weak agonistic" or it can even completely block any pro-inflammatory reactions by binding to corresponding host receptors. The latter lipopolysaccharides are therefore called "antagonistic". Most Gram negative bacteria express agonistic hexaacylated LPS like E. coli LPS, which is one of the most potent agonists of the human innate immune system (Beutler and Rietschel, 2003; Raetz and Whitfield, 2002; Zahringer et al., 1994) (Fig. 4A) . Usually the number of lipid A acyl chains directly correlates with the ability to induce cytokine production whereas the hexaacylated forms usually are the most immunostimulating ones (Munford and Varley, 2006) . Within a biological system, distinct lipid A structures compete for binding to host receptors. Antagonistic lipid A might therefore compete with agonistic LPS for host receptor binding. Hexaacylated lipid A seems to promote the strongest proinflammatory immune reactions after binding to TLR4. This is due to the fact that the first five acyl chains are buried in a hydrophobic cavity of the TLR4 adaptor molecule MD-2 while the sixth chain mediates the binding to TLR4, the precondition for TLR4-mediated intracellular signalling (Maeshima and Fernandez, 2013; Park et al., 2009 ). Therefore, TLR4-mediated signalling usually is drastically reduced if this sixth acyl chain is missing. However, due to the already mentioned differences in the structures of the lipid A binding cavity of the TLR4 receptor between different mammal species, distinct lipid A structures can provide a different immunogenic potential between these species. Fig. 4 summarizes different lipid A structures and their corresponding agonistic or antagonistic properties.
Not only acyl chains contribute to the immunogenic properties of lipid A, but also the number of phosphate groups. A deletion of a phosphate group can result in a loss of the endotoxic activity . Most lipid A structures contain two phosphate residues, one on each sugar moiety. However, some bacterial lipid As lack one or even both of them, therefore altering its immunogenic potential. For example, Francisella tularensis lacks one or both phosphate groups and this is considered to be, at least in part, the reason for its weak agonistic property (Molinaro et al., 2015) (Fig. 4E) . Furthermore, the non-phosphorylation might also be seen as an immune evasion strategy for certain bacteria since some antimicrobial peptides (AMPs) specifically target negative charges on bacterial surfaces and a loss of negatively charged phosphate residues therefore renders bacteria to be invisible for these AMPs. Immunogenic phosphate groups are highlighted in light red. The bold red numbers below each acyl chain refers to the number of carbon atoms of the respective chain. Structural differences of the acyl chains compared to prototype agonistic E. coli lipid A are highlighted in light blue. Structural differences of the disaccharide backbone compared to prototype agonistic E. coli lipid A are highlighted in light yellow. The classification of each lipid A structure as agonistic or antagonistic refers to its immunogenic behaviour due to TLR4 binding. See text for details.
Immune-evasion
Induction of antibacterial defence by triggering inflammatory host responses is a crucial function of the innate immune system in response to invading bacteria. This reaction prevents the spreading of bacteria and suppresses the bacterial growth. In many infections with pathogens, the innate immune responses slow the progress of infection and allow for the adaptive immune responses to develop (Montminy et al., 2006) . Suppressing or evading the host immune responses is a successful strategy of pathogenic bacteria, known as immune-evasion (Montminy et al., 2006) . Immune evasion strategies based on lipid A modification help to promote the survival of Gram negative bacteria by evading host immune responses that are directed against bacterial invasion, chronic persistence or susceptibility to cationic antimicrobial peptides (CAMP) .
As mentioned above, the acylation pattern of lipid A varies between species and is heterogeneous even within a single species (Dixon and Darveau, 2005; Raetz and Whitfield, 2002; Zähringer and Rietschel, 1999) . Environmental conditions are known to influence the lipid A structure by modulating for example the number, composition and location of acyl chains thereby affecting the biological activity of lipid A. The production of weak stimulatory lipid A is thought to be involved in the virulence of several Gram negative pathogens (Dixon and Darveau, 2005) .
An impressive and well-characterized example of lipid A modification as immune evasion mechanism represents Yersinia pestis (Montminy et al., 2006) . Y. pestis grown at 21-28 • C (flea temperature) expresses hexaacylated lipid A structures (Fig. 4H ), but these lipid A structures are mainly tetraacylated at 37 • C (host temperature) (Kawahara et al., 2002; Knirel et al., 2005; Rebeil et al., 2004) (Fig. 4J) . Although hexaacylated lipid A is normally a strong activator of human TLR4, tetraacylated lipid A has a significantly lower activity (Golenbock et al., 1991; Kawahara et al., 2002; Lien et al., 2000; Loppnow et al., 1989; Rebeil et al., 2004) and is thought to act as a TLR4 antagonist . To suppress local inflammatory immune responses, Y. pestis uses several parallel mechanisms that individually are necessary for virulence like e.g. a type 3 secretion system (T3SS), releasing immunosuppressive proteins (Nakajima et al., 1995) . However, evading activation of TLR4 was shown to be an essential part of the Y. pestis immune evasion. The ability of a Y. pestis mutant strain expressing lipid A with an increased capacity to activate TLR4 at 37 • C was dominant over the anti-host bacterial defences provided by the T3SS and other Y. pestis activities (Montminy et al., 2006) . Hence, despite retention of multiple immune evasive proteins used by Y. pestis to suppress host responses, a strain producing hexaacylated lipid A and thus being quickly detectable by means of TLR4-MD-2 failed to cause disease (Montminy et al., 2006) . Similar to Y. pestis, F. tularensis (Fig. 4E) shows a dynamic regulation of lipid A acyl chain length according to temperature (Okan and Kasper, 2013; Needham and Trent, 2013) . F. tularensis has two homologues of the essential lipid A biosytheses acyl transferase LpxD, LpxD1/LpxD2, (Valentin-Hansen et al., 2007) . LpxD1 has its optimum activity at 37 • C and consistent with this the lpxD1 mutant is unable to express the modified lipid A with longer acyl groups and is severely attenuated in mice (Okan and Kasper, 2013; Li et al., 2012) and is also more susceptible to antibiotics and CAMP by reason of an increased membrane permeability (Li et al., 2012; Needham and Trent, 2013) .
Another example of evading the recognition of the host's immune system by modifying the lipid A component of LPS is H. pylori. Despite a robust host immune response, H. pylori persists within the gastric niche and promotes a chronic infection for the duration of the host's life (Gaddy et al., 2015) . H. pylori uses two lipid A based immune evasion strategies, evasion of detection by TLR4 and resistance to CAMP. The lipid A of H. pylori has a unique structure and lower biological activity as compared to lipid A from other bacteria, e.g. E. coli (Chmiela et al., 2014; Moran and Aspinall, 1998; Muotiala et al., 1992) . Interestingly H. pylori synthesizes a hexaacylated lipid A but exhibits a tetraacylated lipid A lacking phosphate groups at its surface (Fig. 4C) . The structural differences are generated by the action of several enzymes including deacylation by LpxR and dephosphorylation by LpxE and LpxF (Gaddy et al., 2015; Needham and Trent, 2013) . Hence H. pylori provides a tetraacetylated antagonistic lipid A structure (Fig. 4C) that not only prevents TLR4-mediated activation of the innate immune system (Moran et al., 1997; Ogawa et al., 2003; Raetz et al., 2007) , but also from Casp11-mediated inflammasome activation (Kayagaki et al., 2013) (Fig. 3B) . Other examples for underacetylated antagonistic lipid A are Rhodobacter sphaeroides (Fig. 4G) and Rhodobacter capsulatus lipid A structures (Rose et al., 1995) .
Many Gram-negative bacteria utilize lipid A modifications to survive the antimicrobial peptide response imposed by the vertebrate host. Altering the bacterial surface charge by e.g. adding positively charged moieties reduces the binding affinity of cationic antimicrobial peptides with the bacterial outer membrane. An important antimicrobial factor is calprotectin. It is a critical component of the host nutrient withholding process, termed nutritional immunity (Gaddy et al., 2015; Gebhardt et al., 2006; Urban et al., 2009) . One mechanism of nutritional immunity is the host induced restricted access for bacteria to essential metals . Calprotectin binds Zn 2+ and Mn 2+ with high affinity which starves bacteria of these essential metals, creating a Zn 2+ and Mn 2+ limited environment. Additionally, calprotectin exhibits antimicrobial activity against numerous Gram-positive and Gram-negative bacteria (Corbin et al., 2008; Damo et al., 2013; Liu et al., 2012; Lusitani et al., 2003; Sohnle et al., 2000; Steinbakk et al., 1990) . Moreover calprotectin has been demonstrated to inhibit H. pylori growth and has the capacity to modify the activity of the cag type IV secretion system. However H. pylori is able to persist in the gastric niche despite this robust immune response. One mechanism allowing for persistence is the modification of the H. pylori lipid A in response to calprotectin. Thereby the lipid A modification pathway is influenced by the host nutritional immune response as the calprotectin dependent restricted access to essential metals like Zn 2+ and Mn 2+ perturbs the function of H. pylori enzymes involved in the lipid A modification pathway, resulting in increased bacterial fitness and increased biofilm formation.
Salmonella enterica subsp. enterica serovar Typhimurium is an intracellular pathogen which causes gastroenteritis in humans. In S. typhimurium the modification of lipid A is controlled by the PhoPQ system which is activated by low Mg 2+ concentrations or CAMPs (Guo et al., 1997; Guo et al., 1998; Raetz et al., 2007) , e.g. by growing cells under Mg 2+ limitation or during growth within macrophage phagosomal vacuoles (Martin-Orozco et al., 2006) . The activation of the PhoPQ and the PmrAB systems results in an addition of phosphoethanolamine and aminoarabinose and to a PagP and PagL dependent acyl chain remodelling (Richards et al., 2012) . In addition LpxO hydrolates S. typhimurium lipid A as part of a coordinated stress response (Moreira et al., 2013; Needham and Trent, 2013) .
Porphyromonas gingivalis which is considered to be an important agent in human periodontal disease exhibits a very large degree of flexibility in the structure of its lipid A (Curtis et al., 2011) . It harbours di-and monophosphorylated and penta-and tetraacylated moieties (Kumada et al., 1995) and in addition a spectrum of nonphosphorylated lipid A species (Rangarajan et al., 2008) . Dependent on the temperature P. gingivalis shifts the lipid A from an inert nonphosphorylated and antagonizing, monophosphorylated, tetra-acylated structure at 37 • C to a monophosphorylated, penta-acylated higher-potency TLR4 agonistic structure at 41 • C (Curtis et al., 2011) . In addition, the lipid A structure of the tetra-acylated nonphosphorylated P. gingivalis grown at 37 • C contributes to the resistance to CAMPs (Coats et al., 2009) .
Other antagonistic lipid A structures
Usually, pathogenic bacteria naturally provide antagonistic lipid A structures as a strategy of immune evasion, since a nonresponse towards their LPS renders them less visible for the host immune system. One of the most known antagonistic lipid A structures for the human TLR4 receptor complex is the so-called lipid Iva (Fig. 4D) . Its backbone structure strongly resembles the structure of agonistic E. coli LPS. In fact, it constitutes a precursor form of mature E. coli lipid A. However, due to a lack of both secondary acyl chains (Fig. 4D ) that are present in E. coli lipid A (Fig. 4A) , it provides strong antagonistic properties with simultaneous high affinity binding to MD-2 and therefore TLR4 (Beutler and Rietschel, 2003; Raetz and Whitfield, 2002; Zahringer et al., 1994) . Although being a strong antagonist for the human TLR4 receptor complex, lipid IVa is a weak agonist for the murine TLR4 receptor complex. This is based in minor structural differences between human and murine MD-2. Whereas lipid IVa binding to human MD-2 results in an upward shift of the phosphorylated disaccharide backbone mediating antagonistic properties, the binding of lipid IVa to the murine MD-2 leads to a similar conformation compared to agonistic hexaacylated lipid A (Ohto et al., 2012) .
Endotoxicity of LPS as a determinant of intestinal inflammation or homoeostasis
It is well accepted that in inflammatory bowel diseases (IBD), chronic inflammatory disorders of the intestine, the mucosal immune system reacts inappropriately towards the intestinal commensal microbiota (Vijay-Kumar and Gewirtz, 2009 ). However no particular microbial species has been consistently linked to IBD pathogenesis, but some symbiotic bacteria species have been shown to prevent inflammatory host responses (Chassaing and Darfeuille-Michaud, 2011; Chow and Mazmanian, 2010; Devkota et al., 2012; Jeon et al., 2012; Round and Mazmanian, 2009) .
The mono-colonization of Il2 −/− mice with E. coli is reported to induce severe colitis, whereas monocolonization with Bacteroides vulgatus does not and B. vulgatus even inhibits the E. coli induced inflammation in co-colonized Il2 −/− mice (Waidmann et al., 2003) . Recently we showed that a low endotoxicity of the intestinal microbiota was associated with mucosal immune homeostasis in a mouse model of chronic intestinal inflammation (Gronbach et al., 2014) . T cell transplanted Rag1 −/− harboring a low endotoxic complex intestinal microbiota, characterized by high numbers of Bacteroidetes and low numbers of Enterobacteriaceae did not develop colitis, whereas T cell transplanted Rag1 −/− mice harboring a high endotoxic complex intestinal microbiota, characterized by high numbers of Enterobacteriaceae and low numbers of Bacteroidetes developed severe intestinal inflammation (Gronbach et al., 2014) . In line with this, feeding of Rag1 −/− mice, harboring the low endotoxic microbiota with commensal but pathobiontic E. coli JM83 resulted in intestinal inflammation, whereas the administration of an E. coli JM83 mutant containing an acyltransferase from P. gingivalis (E. coli MUT ) protected Rag1 −/− mice harboring the high endotoxic microbiota from induction of disease (Bainbridge et al., 2006) . We isolated and purified LPS from both E. coli WT and E. coli MUT and characterized its fatty acid composition. Investigations by high-resolution electrospray ionization Fourier transform ion cyclotron mass spectrometry revealed the same hexaacetylated lipid A molecules in both strains. In addition, E. coli MUT contained a major portion of lipid A, in which a 12 carbon atom laurate acyl chain is replaced by a 16 carbon atom palmitate acyl chain (Gronbach et al., 2014) (Fig. 4A and  B ). This minor modification in E. coli JM83 is reported to significantly affect host cell signaling (Bainbridge et al., 2006) . To verify the altered stimulatory capacity of LPS MUT compared with LPS WT , we used TLR4-overexpressing human embryonic kidney cells (HEK293). Stimulation of cells with the modified LPS MUT resulted in a significantly reduced IL-8 secretion 4 h after stimulation, as compared with LPS WT indicating a reduced endotoxicity but not TLR4 antagonism of the altered LPS MUT . Feeding of Rag1 −/− mice harboring the low endotoxic microbiota with LPS WT resulted in severe intestinal inflammation, however challenging mice which were colonized with the high endotoxic microbiota protected these animal from induction of colitis (Gronbach et al., 2014) . This data suggest that the ratio of high endotoxic and low endotoxic LPS is crucial for the regulation of the intestinal immune balance. A predominance of high endotoxic LPS might promote a TH1/TH17 response, subsequently supporting intestinal inflammation, and a predominance of low endotoxic LPS might induce an altered activation of the innate immune system, and either induction of regulatory T cells or prevention of a TH1/TH17 response, associated with intestinal immune homeostasis (Gronbach et al., 2014) . Therefore LPS might act as a key microbial symbiosis factor that, depending on its structure, can induce or prevent bowel inflammation by shaping the innate immunity via TLR4-dependent signaling mechanisms (Gronbach et al., 2014; Yamamoto and Akira, 2009 ).
LPS as a potential drug for the treatment of inflammatory bowel disease?
The role of LPS for the host immune system provides ambivalent features. While LPS is essential for the host organism to sense infections of bacterial pathogens at an early stage, therefore helping to clear the infection, an imbalanced LPS sensing can have severe effects for the host organism with fatal sepsis being the most severe consequence. Blocking TLR4 mediated downstream signaling has been implicated to be useful as a drug to prevent from septic shock (O'Neill et al., 2009) . Therefore, synthetic antagonistic lipid A structures were invented in order to block TLR4 receptor signaling, such as Eritroran (Fig. 4F) . Eritroran strongly prevents from binding of agonistic lipid A to MD-2 and therefore terminates MD-2/TLR4-mediated signaling in vitro, ex vivo and in vivo (Mullarkey et al., 2003; Rossignol and Lynn, 2002; Rossignol et al., 2004) . Despite these findings, Eritroran failed to improve survival in a phase III trial in patients with severe sepsis (Opal et al., 2013) . Until now, it is not known why Eritroran gavage failed to prevent from fatal sepsis. Possible explanations might be the delayed administration of this strong TLR4 agonist or a failure in trial design (Opal et al., 2013; Tse, 2013) . Nevertheless, antagonistic lipid A structures still seem to be a promising tool for the treatment of bacterially induced sepsis. This strategy to prevent from an uncontrolled, or "imbalanced", TLR4 signalingmediated immune response might also be an attractive approach to deal with inflammatory disorders of the gut. Inflammatory bowel disease develops from an uncontrolled immune response directed towards the intrinsic microbiota. In this case, not pathogens are the target of the immune system, but rather commensal bacteria located in the intestine. It might therefore be possible that antagonistic or weakly agonistic lipid A structures could prevent from uncontrolled TLR4-mediated immune responses towards the own microbiota. In fact, we could already show that the lipid A structure of commensal bacteria is a decisive trigger for the induction of colitis in a genetically predisposed host (Gronbach et al., 2014) .
Two main questions remain concerning the administration of isolated LPS (or lipid A) for the treatment of IBD. (I) Which lipid A structure might provide the best results and (II) is TLR4 blocking really "the method of choice"?
The specific structure of lipid A can have profound and even unpredictable effects upon TLR4 signaling. Although detailed studies about the interaction of lipid A with its corresponding MD-2 co-receptors are available (Ohto et al., 2012; Park et al., 2009 ), the precise immunogenicity cannot be predicted from knowing the structure alone. However, a recent report by Paramo et al. (2015) means a major advance concerning this issue, since they manage to predict the binding behaviour of lipid A structures to MD-2 by measuring their potentials of mean force. The second question is even more complicated to answer. It is possible that TLR4 blocking might not restore homeostasis in every case, since TLR4 signaling seems to be important for the prevention of dextran sodium sulfate (DSS)-induced colitis in mice (Rakoff-Nahoum et al., 2006; Wittmann et al., 2015) . Therefore, an antagonistic lipid A structure, completely preventing from TLR4 signaling, might not be the lipid A of choice. Possibly, a rather weakly agonistic lipid A structure, allowing basic TLR4-mediated signaling, but preventing from uncontrolled TLR4 activation might be a better tool. Additionally, the recent discovery of caspase-11 as an intracellular lipid A binding LPS sensor (Kayagaki et al., 2011 (Kayagaki et al., , 2013 Shi et al., 2014) leads to the question, if blocking the TLR4 binding cavity is sufficient to influence LPS-mediated induction of the host immune system. As described above, a block of TLR4 is not sufficient to prevent from LPS induced Casp11-mediated inflammasome activation. Other bacterial components, largely present in the intestine, can activate other TLRs than TLR4 to induce an increase in cytosolic amounts of Casp11 being a precondition for intracellular lipid A sensing. Therefore, a potential lipid A-derived drug needs to have access to the cytosol of host target cells. Although being highly speculative, this might be another explanation why Eritroran failed in the clinical study since it was not granted access to the cytosolic compartment. This fact rises drug development to a severe challenge and strategies need to be developed to target therapeutic lipid A to the cytosolic compartment. Since it could be shown that lipid A structures that act antagonistically in TLR4-signaling also prevent from Casp11 oligomerization and activation despite efficient binding (Shi et al., 2014) . Therefore, it seems that the immunogenicity of lipid A structure concerning TLR4 activation, described by the terms agonistic and antagonistic, also accounts for intracellular lipid A induced intracellular inflammasome activation.
There is an ongoing research for new lipid A structures in order to be used as therapeutic. Although most research on this topic focuses on the treatment of sepsis, the idea behind it can easily be transferred to the treatment of chronic inflammatory intestinal disorders. Besides synthetic or chemical development of lipid A structure-related TLR4 antagonists, there is an ongoing interest also on LPS structures of more "exotic" bacteria and how they might contribute to a research progress on this topic. For example, Di Lorenzo et al. (2014) identified a lipid A structure with strong antagonistic activity in a bacterium living in hot springs: Thermomonas hydrothermalis (Fig. 4K) . However, a closer and more detailed look on the lipid A structures of symbiotic commensal bacteria might be helpful for the development of a lipid A structure providing weak agonistic activity to prevent from both, TLR4-and Casp11-mediated, uncontrolled immune responses of the host organism towards its own microbiota.
Disclosures
The authors disclose all commercial affiliations and competing financial interests and the authors declare that there is no conflict of interest regarding the publication of this paper.
